Clinical Trials
As more research proves the efficacy of psychedelics in the treatment of depression, anxiety and on improving brain function, an increasing number of clinical trials are being launched. As we find more of these trials, we will add the links here as they open up.
MAC Clinical Research: Depression Study - currently recruiting
Currently enrolling volunteers to study the impact of psilocybin and DMT on depression.
Imperial College London - Microdose Study 2.0
Imperial College's Centre for Psychedelic Research is seeking participants for the second round of its self-blinding microdose project....
Imperial College London - Recruitment for an upcoming trial - DMT Synaptogenesis
There is a growing amount of evidence suggesting that DMT’s anti-depressant action may stem from temporary enhancement of neuroplasticity.. currently seeking volunteers.
King's College London - Psychoactive Trials Group
The Psychoactive Trials Group at the Centre for Affective Disorders is undertaking controlled clinical trials with psychedelics and related compounds such as psilocybin, 5-MeO-DMT and MDMA. Clinical trial currently recruiting volunteers.
Kings College London - Largest trial to date shows that psilocybin reduces depression symptoms
Found that a 25mg dose of psilocybin, alongside psychological support, had a significant impact in reducing symptoms of depression in participants with treatment-resistant depression.
Clerkenwell Health
Access novel mental health and CNS treatments including psychedelic therapy by participating in clinical trials. Currently recruiting volunteers for a trial to study the efficacy of DMT in alcohol use disorder.
Connect
enquiries@mduk.net
Stay up to date
Telegram
@MDUKNET